110 related articles for article (PubMed ID: 11774741)
1. Hammerhead ribozymes to modulate telomerase activity of endometrial carcinoma cells.
Yokoyama Y; Wan X; Shinohara A; Takahashi Y; Tamaya T
Hum Cell; 2001 Sep; 14(3):223-31. PubMed ID: 11774741
[TBL] [Abstract][Full Text] [Related]
2. The 5'-end of hTERT mRNA is a good target for hammerhead ribozyme to suppress telomerase activity.
Yokoyama Y; Takahashi Y; Shinohara A; Wan X; Takahashi S; Niwa K; Tamaya T
Biochem Biophys Res Commun; 2000 Jun; 273(1):316-21. PubMed ID: 10873604
[TBL] [Abstract][Full Text] [Related]
3. Attenuation of telomerase activity by hammerhead ribozymes targeting human telomerase RNA and telomerase reverse transcriptase in pancreatic carcinoma cells.
Hayashidani Y; Hiyama E; Murakami Y; Sueda T
Hiroshima J Med Sci; 2005 Mar; 54(1):21-7. PubMed ID: 15847061
[TBL] [Abstract][Full Text] [Related]
4. Attenuation of telomerase activity by a hammerhead ribozyme targeting the template region of telomerase RNA in endometrial carcinoma cells.
Yokoyama Y; Takahashi Y; Shinohara A; Lian Z; Wan X; Niwa K; Tamaya T
Cancer Res; 1998 Dec; 58(23):5406-10. PubMed ID: 9850072
[TBL] [Abstract][Full Text] [Related]
5. [Attenuation of telomerase activity by hammerhead ribozyme targeting the 5'-end of hTERT mRNA].
Qu Y; Liu S; Liu B
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2002 Oct; 19(5):389-92. PubMed ID: 12362313
[TBL] [Abstract][Full Text] [Related]
6. [Application of hammerhead ribozyme targeting telomerase molecule for cancer therapy].
Yokoyama Y; Takahashi Y; Shinohara A; Tamaya T
Nihon Rinsho; 1998 May; 56(5):1126-30. PubMed ID: 9613108
[TBL] [Abstract][Full Text] [Related]
7. Attenuation of telomerase activity by hammerhead ribozyme targeting human telomerase RNA induces growth retardation and apoptosis in human breast tumor cells.
Yeo M; Rha SY; Jeung HC; Hu SX; Yang SH; Kim YS; An SW; Chung HC
Int J Cancer; 2005 Apr; 114(3):484-9. PubMed ID: 15551309
[TBL] [Abstract][Full Text] [Related]
8. Divalent hammerhead ribozyme targeting template region of human telomerase RNA has potent cleavage activity, but less inhibitory activity on telomerase.
Yokoyama Y; Wan X; Takahashi Y; Shinohara A; Liulin T; Tamaya T
Arch Biochem Biophys; 2002 Sep; 405(1):32-7. PubMed ID: 12176054
[TBL] [Abstract][Full Text] [Related]
9. [Hammerhead ribozyme against human telomerase catalytic subunit (hTERT) induced apoptosis of liver cancer cells].
Song DP; Lin JS; Fu GL; Sun XM; Kong XJ; Li PY; Ma X
Zhonghua Gan Zang Bing Za Zhi; 2004 Oct; 12(10):616-9. PubMed ID: 15504295
[TBL] [Abstract][Full Text] [Related]
10. [Inhibition of telomerase activity by ribozyme targeted to human telomerase transcriptase].
Qu Y; Liu SQ; Peng WZ; Liu BL
Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai); 2002 May; 34(3):323-8. PubMed ID: 12019445
[TBL] [Abstract][Full Text] [Related]
11. Antitumor activity of systemically delivered ribozymes targeting murine telomerase RNA.
Nosrati M; Li S; Bagheri S; Ginzinger D; Blackburn EH; Debs RJ; Kashani-Sabet M
Clin Cancer Res; 2004 Aug; 10(15):4983-90. PubMed ID: 15297398
[TBL] [Abstract][Full Text] [Related]
12. Ribozyme cleavage of telomerase mRNA sensitizes breast epithelial cells to inhibitors of topoisomerase.
Ludwig A; Saretzki G; Holm PS; Tiemann F; Lorenz M; Emrich T; Harley CB; von Zglinicki T
Cancer Res; 2001 Apr; 61(7):3053-61. PubMed ID: 11306487
[TBL] [Abstract][Full Text] [Related]
13. Specific regression of human cancer cells by ribozyme-mediated targeted replacement of tumor-specific transcript.
Kwon BS; Jung HS; Song MS; Cho KS; Kim SC; Kimm K; Jeong JS; Kim IH; Lee SW
Mol Ther; 2005 Nov; 12(5):824-34. PubMed ID: 16040278
[TBL] [Abstract][Full Text] [Related]
14. Validation of tissue-specific promoter-driven tumor-targeting trans-splicing ribozyme system as a multifunctional cancer gene therapy device in vivo.
Song MS; Jeong JS; Ban G; Lee JH; Won YS; Cho KS; Kim IH; Lee SW
Cancer Gene Ther; 2009 Feb; 16(2):113-25. PubMed ID: 18758435
[TBL] [Abstract][Full Text] [Related]
15. Non-enzymatic in vitro production of circular hammerhead ribozyme targeting the template region of human telomerase RNA.
Ochi A; Umekage S; Kikuchi Y
Nucleic Acids Symp Ser (Oxf); 2009; (53):275-6. PubMed ID: 19749367
[TBL] [Abstract][Full Text] [Related]
16. Telomerase inhibition strategies by siRNAs against either hTR or hTERT in oral squamous cell carcinoma.
Li Y; Li M; Yao G; Geng N; Xie Y; Feng Y; Zhang P; Kong X; Xue J; Cheng S; Zhou J; Xiao L
Cancer Gene Ther; 2011 May; 18(5):318-25. PubMed ID: 21233858
[TBL] [Abstract][Full Text] [Related]
17. Knockdown of telomerase RNA using hammerhead ribozymes and RNA interference.
Li S; Nosrati M; Kashani-Sabet M
Methods Mol Biol; 2007; 405():113-31. PubMed ID: 18369821
[TBL] [Abstract][Full Text] [Related]
18. Gene expression responses in vivo by human telomerase reverse transcriptase (hTERT)-targeting trans-splicing ribozyme.
Song MS; Jeong JS; Cho KS; Lee SW
Exp Mol Med; 2007 Dec; 39(6):722-32. PubMed ID: 18160843
[TBL] [Abstract][Full Text] [Related]
19. [Construction and screening of a ribozyme targeting telomerase RNA and effects of telomerase ribozyme on proliferation and apoptosis of CNE-2Z cells].
Zhao YH; Chen XY; R Arrand J
Ai Zheng; 2004 Jan; 23(1):50-5. PubMed ID: 14720374
[TBL] [Abstract][Full Text] [Related]
20. Ribozyme-mediated telomerase inhibition induces immediate cell loss but not telomere shortening in ovarian cancer cells.
Saretzki G; Ludwig A; von Zglinicki T; Runnebaum IB
Cancer Gene Ther; 2001 Oct; 8(10):827-34. PubMed ID: 11687906
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
